Investigation on hybrid molecules as powerful novel therapeutic approaches for Multiple Sclerosis and myelin-related rare diseases
Funding :
Duration: 2019 - 2022
PI:
Fundación Ramón Areces
Duration: 2019 - 2022
PI:
IP: V Palomo, F de Castro